• 대한의용생체공학회:의공학회지
• /
• 제44권1호
• /
• pp.73-79
• /
• 2023

The purpose of this study is to derive medical devices with different management systems through comparison of domestic and overseas medical device product classification systems and to propose management conversion measures for the products. The definitions of medical devices were compared and the scope of medical devices defined by each country was confirmed through surveys of the Medical Device Act, Federal Food, Drug & Cosmetics Act (FD&C) in the U.S., and Medical Device Regulations (MDR) in Europe. Using the Ministry of Food and Drug Safety's regulations on medical device products and grades, 21 CFR part 860-892 and product code classification files in U.S., and EMDN in Europe as basic data to compare medical device products and derive medical devices with different management systems. As a result of comparing the definition and product classification systems of medical devices in Korea, the U.S. and Europe, medical device accessories, prosthetic limbs and aids among assistive devices for persons with disabilities, drugs, quasi-drugs and industrial products that are not managed by medical devices in Korea are managed as medical devices in the U.S. and Europe. This study aims to improve public health by securing systematic product safety management and essential performance under medical device regulations. Management within a single medical device system will increase the efficiency of licensing work of domestic medical device manufacturers and related organizations. It is also expected to help advance the system according to the international harmony of the item classification system and enhance smooth import and export competitiveness.

• 대한의용생체공학회:의공학회지
• /
• 제40권1호
• /
• pp.20-31
• /
• 2019

Medical device performance management is an activity that allows a device to be safely used and maintained even after it is put on the market. The purpose of this study is to provide procedures and criteria for selection of medical device items that should manage the safety and performance among medical devices in hospital. Investigate the performance management status of medical devices in hospitals and identify the performance management status by domestic and advanced regulatory agencies. Provides selection procedures and test methods for medical devices subject to performance management in hospitals based on medical device risk management and reliability. In addition, a case study on drug infusion pumps was conducted.

• 한국정보통신학회:학술대회논문집
• /
• 한국정보통신학회 2012년도 추계학술대회
• /
• pp.495-497
• /
• 2012

의료기기 소프트웨어 테스트 위험관리 적용 방안에 대해 연구하였다. 먼저 설문조사를 통해 의료기기 제조업체의 소프트웨어 밸리데이션 및 위험관리 현황을 분석하고 두 번째로 블랙박스 테스트와 화이트 박스 테스트를 비교하여 차이점을 분석하였다. 세 번째로 소프트웨어 분석 도구를 활용한 코드 분석 후 잠재적인 위해요인을 도출하고 이를 정량화 하였으며, 마지막으로 도출된 위해요인을 FMEA 기법을 이용하여 의료기기 위험관리 프로세스에 적용할 수 있도록 프레임워크를 구축하였다. 이를 통해 의료기기 품질관리(GMP) 업무 중 소프트웨어 밸리데이션 및 위험관리 프로세스를 구축하기 어려운 제조업체를 위한 업무 지원에 활용하고자 한다.

• 대한의용생체공학회:의공학회지
• /
• 제44권1호
• /
• pp.41-52
• /
• 2023

With the international change in the medical device market owing to the development of innovative medical engineering and the use of various raw materials, a systematic and rational medical device classification system is needed to safely manage newly developed medical devices. This study aims to improve the domestic medical device classification system by proposing product establishment and segmentation. It is based on medical device products from the United States and Europe that are only available in foreign systems and are more subdivided than domestic products. This study analyzes and compares the domestic and foreign medical device classification systems by examining laws, guidelines, and analysis reports in Korea, the United States, and Europe. In accordance with product establishment and segmentation criteria, products subject to improvement are presented. This study contributes to safely managing medical devices that do not fit with the current classification system and to solving the confusion caused by the lack of international harmony in product classification systems.

• 대한의용생체공학회:의공학회지
• /
• 제44권1호
• /
• pp.1-10
• /
• 2023

With the announcement of MEDICAL DEVICE REGULATION 2017/745 (MDR) on April 5 2017, medical device manufacturers shall apply ISO 14971:2019 (3^rd) revised in December 2019. However, there is not much related information and guidance available to medical device manufacturers, especially single use medical device. Risk management process basically follow 5 steps which are Risk Analysis, Risk Evaluation, Risk Control, Evaluation of overall residual risk and post-production activities. The purpose of this study is to provide a guidance of from risk analysis with Failure Mode and Effects Analysis (FMEA) table to overall residual risk evaluation for the single use medical device and to reflect it in a Periodic Safety Update Reports (PSUR) to satisfy with MDR requirements with single use medical device which are widely used and manufactured FDA class 2 or CE class IIb as examples. For this study, single use medical device manufacturer can adopt ISO 14971:2019 in accordance with MDR requirements and it can be extended to the PSUR. But there are still limitations to adopt to the all-single use medical device especially high class, private device and implantable device. So, Competent Authority (CA) shall publish more guidance for the single use medical device.

• 대한의용생체공학회:의공학회지
• /
• 제44권2호
• /
• pp.99-108
• /
• 2023

According to the COVID-19, development of various medical software based on IoT(Internet of Things) was accelerated. Especially, interest in a central software system that can remotely monitor and control ventilators is increasing to solve problems related to the continuous increase in severe COVID-19 patients. Since medical device software is closely related to human life, this study aims to develop central monitoring system that can remotely monitor and control multiple ventilators in compliance with medical device software development standards and to verify performance of system. In addition, to ensure the safety and reliability of this central monitoring system, this study also specifies risk management requirements that can identify hazardous situations and evaluate potential hazards and confirms the implementation of cybersecurity to protect against potential cyber threats, which can have serious consequences for patient safety. As a result, we obtained medical device software manufacturing certificates from MFDS(Ministry of Food and Drug Safety) through technical documents about performance verification, risk management and cybersecurity application.

• 대한의용생체공학회:의공학회지
• /
• 제44권5호
• /
• pp.315-323
• /
• 2023

The objective of this study is to identify the selective application targets for reporting on details of supply of class 1 and 2 medical devices as part of the improvement of the reports on details of supply of medical device system, and to analyze its effectiveness. Therapeutic materials covered by health insurance and secondhand medical devices were chosen based on the transparency of health insurance coverage and the management of medical device distribution. As a result, approximately 85% of groups can be excluded from the reporting requirements compared to reporting all items under Class 1 and 2 medical devices. This is expected to enhance the efficiency of supply reporting tasks. Additionally, the information on supply details managed by the regulatory authority can be utilized for statistical analysis and periodic monitoring, serving as fundamental data for the development of medical device-related policies and research in the field of medical devices.

• 품질경영학회지
• /
• 제50권3호
• /
• pp.503-515
• /
• 2022

Purpose: As ISO 13485 was revised in 2016, the domestic GMP (Good Manufacturing Practice) system was also revised and implemented in 2019. However, there are many problems in the domestic medical device industry because most of the small and medium-sized enterprises lack human and material resources. Accordingly, this study was conducted to provide education programs for domestic medical device companies to induce information provision and improve the company's quality management ability. Methods: First, analyze existing education. Second, based on the revised GMP system, a survey paper was produced to investigate difficulties and problems experienced by companies. Third, a two-week survey was conducted on domestic medical device manufacturers, and a total of 77 companies responded to this survey. Fourth, educational program development was conducted based on the results of the survey. Results and Conclusion: The developed education program consists of a total of five sessions. In this study, the educational program developed by grasping the needs of the company through a survey consists of a total of five sessions. The first session consisted of theoretical education and the second to fifth sessions of practical education. Through the education program developed in this study, it is expected to contribute to the overall development of medical device quality by establishing a domestic medical device manufacturing environment that secures the safety and performance of domestic medical device companies.

• 대한의용생체공학회:의공학회지
• /
• 제44권1호
• /
• pp.19-24
• /
• 2023

Due to the spread of COVID-19, many patients with severe respiratory diseases have occurred worldwide, and accordingly, the use of mechanical ventilators has exploded. However, hospitals do not have systematic risk management, and the Medical Device Regulation also provides medical device risk management standards for manufacturers, but does not apply to devices in use. In this paper, we applied the Failure Mode Effects Analysis (FMEA) risk analysis technique based on the International Standard ISO 14971 (Medical Devices-Application of risk management to medical devices) for 85 mechanical ventilators of a specific model in use in hospitals. Failure modes and effects of each parts were investigated, and risk priority was derived through multiplication of each score by preparing criteria for severity, occurrence, and detection for each failure mode. As a result, it was confirmed that the microprocessor-based Patient Unit/Monitoring board in charge of monitoring scored the highest score with 36 points, and that reliability management is possible through systematic risk management according to priority.

• 정보처리학회논문지:소프트웨어 및 데이터공학
• /
• 제6권12호
• /
• pp.543-548
• /
• 2017

최근에는 의료기기의 구성 요소 중 소프트웨어의 기능과 역할이 커지고, 의료기기 소프트웨어의 작동이 사용자의 생명과 안전에 직결되는 특성으로 인해 의료기기 소프트웨어의 안전성 보장에 대한 중요함은 더욱 강조되고 있다. 이를 위해 의료기기의 안전성을 효과적으로 보장할 수 있는 활동과 각각의 요구사항들을 제시하고 있는 여러 표준이 제정되었다. 표준들이 의료기기 소프트웨어의 안전성을 보장하기 위해 제시하는 활동으로는 크게 의료기기 소프트웨어의 개발생명주기와 위험관리 프로세스로 나뉜다. 이 두 활동은 개발 과정 중 동시에 진행되어야 하지만, 의료기기 소프트웨어 개발생명주기의 각 단계에서 수행되어야하는 위험관리 요구사항들은 분류되어있지 않다는 한계점이 있다. 이로 인해 개발자들은 의료기기 개발 중에 직접 표준들의 연관성을 분석하여 위험관리 활동을 수행해야한다. 따라서 본 논문에서는 의료기기 소프트웨어 개발생명주기와 위험관리 프로세스의 연관성을 분석하고, 위험관리 요구사항 항목들을 추출한다. 그리고 분석한 연관성을 토대로 추출된 위험관리 요구사항 항목을 개발생명주기에 대응시킴으로서, 의료기기 소프트웨어의 개발 중 효과적이고 체계적인 위험관리를 가능하게 한다.